About NovelStem
NovelStem is a company based in Boca Raton (United States) founded in 1993 by Mitchell Rubenstein.. NovelStem has raised $700 thousand across 2 funding rounds from investors including PJ SOLOMON. NovelStem offers products and services including Diagnostic Technology and Net Force Publishing Franchise. NovelStem operates in a competitive market with competitors including Isabl, CytoSite Bio, Probiont, AccuTheranostics and Precision Therapeutics, among others.
- Headquarter Boca Raton, United States
- Founders Mitchell Rubenstein
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Novelstem International Corp.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-3.23 M23.45as on Dec 31, 2024
-
EBITDA
$-880.95 K-32.42as on Dec 31, 2024
-
Total Equity Funding
$700 K (USD)
in 2 rounds
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NovelStem
NovelStem offers a comprehensive portfolio of products and services, including Diagnostic Technology and Net Force Publishing Franchise. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Predicts drug resistance for targeted cancer therapies using stem cells.
Manages book series relaunch and licensing agreements.
Funding Insights of NovelStem
NovelStem has successfully raised a total of $700K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(02 Dec 2010)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2016 | Amount | Private Equity Round - NovelStem | Valuation | PJ SOLOMON |
|
| Dec, 2010 | Amount | Unspecified - NovelStem | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NovelStem
NovelStem has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include PJ SOLOMON. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
M&A advisory and restructuring services are provided across sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NovelStem
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NovelStem
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novelstem Comparisons
Competitors of NovelStem
NovelStem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Isabl, CytoSite Bio, Probiont, AccuTheranostics and Precision Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cancer patients' genomes are analyzed by a medical diagnosis platform.
|
|
| domain | founded_year | HQ Location |
Precision imaging products for immuno-oncology therapy are developed.
|
|
| domain | founded_year | HQ Location |
Developing personalized solutions for cancer immunotherapy testing with organ-on-a-chip technology.
|
|
| domain | founded_year | HQ Location |
Personalized chemotherapy response testing is offered for cancer patients.
|
|
| domain | founded_year | HQ Location |
Precision Therapeutics develops a platform for innovative, personalized cancer therapies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Novelstem
Frequently Asked Questions about NovelStem
When was NovelStem founded?
NovelStem was founded in 1993 and raised its 1st funding round 17 years after it was founded.
Where is NovelStem located?
NovelStem is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.
Who is the current CEO of NovelStem?
Mitchell Rubenstein is the current CEO of NovelStem. They have also founded this company.
Is NovelStem a funded company?
NovelStem is a funded company, having raised a total of $700K across 2 funding rounds to date. The company's 1st funding round was a Unspecified of $700K, raised on Dec 02, 2010.
What does NovelStem do?
NovelStem was founded in 1993 and is headquartered in Boca Raton, United States. Operations focus on biotechnology, where proprietary haploid human embryonic stem cell technology, known as NewStem, is utilized to create diagnostics that predict patient resistance to cancer chemotherapies. Additional efforts include development of therapeutics and applications in reproductive medicine.
Who are the top competitors of NovelStem?
NovelStem's top competitors include CytoSite Bio, Isabl and Probiont.
What products or services does NovelStem offer?
NovelStem offers Diagnostic Technology and Net Force Publishing Franchise.
Who are NovelStem's investors?
NovelStem has 1 investor. Key investors include PJ SOLOMON.